|
⚲
|
| Keyboard |
| Apimeds Pharmaceuticals US Inc
✚
|
|
|---|---|
| CIK # | 0001894525 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001894525] | |
| 10-Q | [0001894525] | |
| 3 | [0001894525] | |
| 4 | [0001894525] | |
| 8-K | [0001894525] | |
| SC 13D | [0001894525] | |
| SC 13G | [0001894525] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Ayrton Capital LLC | Apimeds Pharmaceuticals US Inc | [2026-02-11] |
| Inscobee Inc | Apimeds Pharmaceuticals US Inc | [2025-05-19] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Apimeds Pharmaceuticals US Inc | |
| Koo Jakap | |
| Yoon Hankil | |
| Weintraub Bennett | |
| Kogan Elona | |
| O'Donnell Carol A | |
| Kim Christopher | |
| Emerson Erik | |
| Inscobee Inc | |
| Corrao Mark |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-11-11 | Grant | 10,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-11-11 | Grant | 10,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-11-11 | Grant | 10,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-11-11 | Grant | 10,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-11-11 | Grant | 10,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 3,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 215,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 3,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 3,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 3,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 3,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 3,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-05-16 | Grant | 5,780 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-16 | Grant | 750,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock option (right to buy) · derivative
|
2025-05-16 | Grant | 347,279 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-16 | Grant | 250,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-05-16 | Grant | 5,780 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-05-16 | Grant | 5,780 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-05-16 | Grant | 5,780 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-05-16 | Grant | 5,780 | $0.00 | |
| showing 20 of 30 most recent transactions | |||||